This oral tablet combines three distinct compounds—SLU-PP-332, 5-Amino-1MQ, and BPC-157—each selected for its unique biological activity.
SLU-PP-332 is associated with metabolic activation pathways, often studied in models exploring energy balance and endurance.
5-Amino-1MQ has been investigated for its potential role in modulating fat metabolism and NAD+ pathways.
BPC-157 contributes properties linked to tissue regeneration, inflammation control, and gut lining support.
Combined in one oral formulation, these compounds offer a versatile platform for examining cellular recovery, metabolic support, and structural integrity in various systems.
